Literature DB >> 34750649

Individualized glycaemic management for critically ill patients. Authors' reply.

Julien Bohé1, Jean-Charles Preiser2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34750649     DOI: 10.1007/s00134-021-06572-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Near-Continuous Glucose Monitoring Makes Glycemic Control Safer in ICU Patients.

Authors:  Jean-Charles Preiser; Olivier Lheureux; Aurelie Thooft; Serge Brimioulle; Jacques Goldstein; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2018-08       Impact factor: 7.598

Review 2.  Glucose Control in the ICU: A Continuing Story.

Authors:  Jean-Charles Preiser; J Geoffrey Chase; Roman Hovorka; Jeffrey I Joseph; James S Krinsley; Christophe De Block; Thomas Desaive; Luc Foubert; Pierre Kalfon; Ulrike Pielmeier; Tom Van Herpe; Jan Wernerman
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

3.  Individualized glycemic management for critically ill patients.

Authors:  Tomoya Okazaki; Akihiko Inoue; Yasuhiro Kuroda
Journal:  Intensive Care Med       Date:  2021-10-21       Impact factor: 17.440

4.  Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial.

Authors:  Julien Bohé; Hassane Abidi; Vincent Brunot; Amna Klich; Kada Klouche; Nicholas Sedillot; Xavier Tchenio; Jean-Pierre Quenot; Jean-Baptiste Roudaut; Nicolas Mottard; Fabrice Thiollière; Jean Dellamonica; Florent Wallet; Bertrand Souweine; Alexandre Lautrette; Jean-Charles Preiser; Jean-François Timsit; Charles-Hervé Vacheron; Ali Ait Hssain; Delphine Maucort-Boulch
Journal:  Intensive Care Med       Date:  2021-09-29       Impact factor: 17.440

  4 in total
  2 in total

1.  Individualized glycemic management for critically ill patients.

Authors:  Tomoya Okazaki; Akihiko Inoue; Yasuhiro Kuroda
Journal:  Intensive Care Med       Date:  2021-10-21       Impact factor: 17.440

2.  Impact of prolonged requirement for insulin on 90-day mortality in critically ill patients without previous diabetic treatments: a post hoc analysis of the CONTROLING randomized control trial.

Authors:  François Thouy; Julien Bohé; Bertrand Souweine; Hassane Abidi; Jean-Pierre Quenot; Fabrice Thiollière; Jean Dellamonica; Jean-Charles Preiser; Jean-François Timsit; Vincent Brunot; Amna Klich; Nicholas Sedillot; Xavier Tchenio; Jean-Baptiste Roudaut; Nicolas Mottard; Hervé Hyvernat; Florent Wallet; Pierre-Eric Danin; Julio Badie; Richard Jospe; Jérôme Morel; Ali Mofredj; Abdelhamid Fatah; Jocelyne Drai; Anne Mialon; Ali Ait Hssain; Alexandre Lautrette; Eric Fontaine; Charles-Hervé Vacheron; Delphine Maucort-Boulch; Kada Klouche; Claire Dupuis
Journal:  Crit Care       Date:  2022-05-16       Impact factor: 19.334

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.